Please sign in so that we can notify you about a reply
Indications/Uses
It is a beta-blocker used by eye drops route.
This medicine is prescribed for the treatment of certain types of eye disease involving intraocular hypertension e.g. glaucoma and intraocular hypertension.
This medicine is prescribed for the treatment of certain types of eye disease involving intraocular hypertension e.g. glaucoma and intraocular hypertension.
Dosage/Direction for Use
Follow the doctor's instructions very carefully when using (Timolol maleate) TIMABAK eye drops solution. If in doubt ask the doctor or pharmacist.
As a guideline, the usual dosage is 1 drop in the affected eye, twice daily (morning and evening).
Premature babies, newborns and infants: the use of this eye drops solution is not recommended.
Means of administration: Eye drops route. This medicine is intended to be used in the eye.
DO NOT INJECT. DO NOT SWALLOW.
Wash the hands carefully before instilling the drops.
Avoid touching eye or eyelids with the tip.
Look upwards and pull the lower lid of the eye down slightly and instill 1 drop.
After using Timolol maleate (TIMABAK) eye drops solution press the finger on the corner of the eye next to the nose for 2 minutes. This helps to prevent timolol diffusing into the rest of the body.
Put the cap back on the bottle after use.
Frequency of administration: Apply twice daily (morning and evening).
The ophthalmologist will advise on the time of day to apply.
Duration of treatment: Follow the doctor's prescription.
Use in children: Dosage: Great care in assessing the risks and benefits before considering any treatment with Timolol. If the benefits outweigh the risks, it is recommended to use the smallest possible concentration available of the active ingredient once daily.
Concerning "use in children", the concentration of 0.1% of active ingredient may be sufficient to control the internal eye pressure. If this dosage does not provide sufficient control of the pressure, it may be necessary to instill the drops twice daily at 12 hours interval. Patients, particularly newborns, must be closely monitored for one to two hours after the first administration; any side effects must be monitored very carefully up to surgery.
Duration of treatment: In infants and young children, Timolol maleate (TIMABAK) eye drops solution will be prescribed as part of a transitional treatment.
If the patient forgets to take Timolol maleate (TIMABAK) eye drops solution: Take Timolol maleate (TIMABAK) eye drops solution as proscribed by the doctor.
Do not take a double dose to compensate for the dose the patient forgot to take. Instill the forgotten dose as soon as possible. However, if it is nearly time to take the next dose; do not instill the forgotten dose.
Effects that may appear on discontinuing treatment with Timolol maleate (TIMABAK) eye drops solution: If the patient interrupts the treatment, the intraocular pressure may increase and impair vision. Do not discontinue treatment without the doctor's advice.
As a guideline, the usual dosage is 1 drop in the affected eye, twice daily (morning and evening).
Premature babies, newborns and infants: the use of this eye drops solution is not recommended.
Means of administration: Eye drops route. This medicine is intended to be used in the eye.
DO NOT INJECT. DO NOT SWALLOW.
Wash the hands carefully before instilling the drops.
Avoid touching eye or eyelids with the tip.
Look upwards and pull the lower lid of the eye down slightly and instill 1 drop.
After using Timolol maleate (TIMABAK) eye drops solution press the finger on the corner of the eye next to the nose for 2 minutes. This helps to prevent timolol diffusing into the rest of the body.
Put the cap back on the bottle after use.
Frequency of administration: Apply twice daily (morning and evening).
The ophthalmologist will advise on the time of day to apply.
Duration of treatment: Follow the doctor's prescription.
Use in children: Dosage: Great care in assessing the risks and benefits before considering any treatment with Timolol. If the benefits outweigh the risks, it is recommended to use the smallest possible concentration available of the active ingredient once daily.
Concerning "use in children", the concentration of 0.1% of active ingredient may be sufficient to control the internal eye pressure. If this dosage does not provide sufficient control of the pressure, it may be necessary to instill the drops twice daily at 12 hours interval. Patients, particularly newborns, must be closely monitored for one to two hours after the first administration; any side effects must be monitored very carefully up to surgery.
Duration of treatment: In infants and young children, Timolol maleate (TIMABAK) eye drops solution will be prescribed as part of a transitional treatment.
If the patient forgets to take Timolol maleate (TIMABAK) eye drops solution: Take Timolol maleate (TIMABAK) eye drops solution as proscribed by the doctor.
Do not take a double dose to compensate for the dose the patient forgot to take. Instill the forgotten dose as soon as possible. However, if it is nearly time to take the next dose; do not instill the forgotten dose.
Effects that may appear on discontinuing treatment with Timolol maleate (TIMABAK) eye drops solution: If the patient interrupts the treatment, the intraocular pressure may increase and impair vision. Do not discontinue treatment without the doctor's advice.
Overdosage
If patient has instilled too many drops or accidentally swallowed the contents of the bottle, the patient may, in addition to other side effects, feel empty-headed, have difficulty breathing or feel the pulse rate slow down; in this case CONTACT THE DOCTOR IMMEDIATELY.
Contraindications
Never use Timolol maleate (TIMABAK) eye drops solution in the following cases: Allergy to one of the components of the eye drops solution; cardiac insufficiency not controlled by medication (heart function failure not controlled by the treatment); cardiogenic shock (shock of cardiac origin); Prinzmetal's angina (type of angina attack); sinus dysfunction of the heart (including sino-auricular block); bradycardia (pulse less than 45-50 beats per minute) (slowed heart rhythm); cardiac conduction disorders (second and third degree atrioventricular block); Raynaud's disease and peripheral circulatory disturbances (symmetrical circulatory disturbances in the fingers with numbness and peripheral arterial disturbances); untreated phaeochromocytoma (excessive hormone production causing severe arterial hypertension); hypotension; treatment with floctafenine; treatment with sultopride (medicine used mostly for psychiatric therapy); asthma and chronic pulmonary and bronchial disease with obstruction (except on doctor's advice).
This medicine should generally not be taken in combination with amiodarone, certain calcium antagonists (bepridil, verapamil, diltiazem) and beta-blockers used to treat heart failure.
This medicine should generally not be taken in combination with amiodarone, certain calcium antagonists (bepridil, verapamil, diltiazem) and beta-blockers used to treat heart failure.
Special Precautions
Do not stop treatment suddenly without the doctor's advice.
Do not inject. Do not swallow.
Periodic ophthalmological examination should be performed while undergoing this treatment, in particular, to check for drug resistance (loss of drug efficacy during long term treatment).
Before using this medicine, tell the doctor of any current or previous occurrence of the following medical conditions: coronary heart disease (symptoms may include pain or tightness in the chest, shortness of breath or choking), heart failure or Crop in blood pressure (hypotension); heart rhythm disorders, such as a slow pulse; respiratory problems, asthma or chronic pulmonary or bronchial disease with obstruction; poor blood circulation (such as Raynaud's syndrome or disease); diabetes - as timolol may mask the signs and symptoms of hypoglycaemia; an overactive thyroid - as timolol may mask the signs and symptoms; phaeochromocytoma: this will require careful monitoring of the patient's arterial pressure; psoriasis (skin disorder).
lf patient has to undergo surgery, tell the doctor that the patient is using TIMABAK as timolol may modify the effects of certain drugs used during anaesthesia
Athletes: The attention of sports professionals is drawn to the fact that this medicinal product contains an active ingredient, which can induce a positive reaction in anti-doping tests.
Driving vehicles and operating machines: The patient may have temporary blurred eyesight after ocular administration of the product. Wait until vision returns to normal before driving vehicles or operating machines. Timolol maleate (TIMABAK) may also cause other side effects (dizziness, fatigue) liable to affect the ability to drive or operate machines. If in doubt, seek the doctor's advice.
Use in paediatric population: Eye drops solutions containing Timolol must always be used with caution with young patients. Timolol must be used with extreme caution with newborns, infants and young children. If the patient develops symptoms such as coughing, wheezing, abnormal breathing or abnormal pauses in breathing (apnea), the use of this product should be discontinued immediately. Contact the doctor as soon as possible. A portable apnea monitor may also be useful.
Timolol has been studied in infants and young children aged from 12 days to 5 years presenting with increased pressure in one or both eyes or who have been diagnosed with glaucoma. See the doctor for more information.
Do not inject. Do not swallow.
Periodic ophthalmological examination should be performed while undergoing this treatment, in particular, to check for drug resistance (loss of drug efficacy during long term treatment).
Before using this medicine, tell the doctor of any current or previous occurrence of the following medical conditions: coronary heart disease (symptoms may include pain or tightness in the chest, shortness of breath or choking), heart failure or Crop in blood pressure (hypotension); heart rhythm disorders, such as a slow pulse; respiratory problems, asthma or chronic pulmonary or bronchial disease with obstruction; poor blood circulation (such as Raynaud's syndrome or disease); diabetes - as timolol may mask the signs and symptoms of hypoglycaemia; an overactive thyroid - as timolol may mask the signs and symptoms; phaeochromocytoma: this will require careful monitoring of the patient's arterial pressure; psoriasis (skin disorder).
lf patient has to undergo surgery, tell the doctor that the patient is using TIMABAK as timolol may modify the effects of certain drugs used during anaesthesia
Athletes: The attention of sports professionals is drawn to the fact that this medicinal product contains an active ingredient, which can induce a positive reaction in anti-doping tests.
Driving vehicles and operating machines: The patient may have temporary blurred eyesight after ocular administration of the product. Wait until vision returns to normal before driving vehicles or operating machines. Timolol maleate (TIMABAK) may also cause other side effects (dizziness, fatigue) liable to affect the ability to drive or operate machines. If in doubt, seek the doctor's advice.
Use in paediatric population: Eye drops solutions containing Timolol must always be used with caution with young patients. Timolol must be used with extreme caution with newborns, infants and young children. If the patient develops symptoms such as coughing, wheezing, abnormal breathing or abnormal pauses in breathing (apnea), the use of this product should be discontinued immediately. Contact the doctor as soon as possible. A portable apnea monitor may also be useful.
Timolol has been studied in infants and young children aged from 12 days to 5 years presenting with increased pressure in one or both eyes or who have been diagnosed with glaucoma. See the doctor for more information.
Use In Pregnancy & Lactation
Do not use Timolol maleate (TIMABAK) eye drops solution if the patient is pregnant, unless the doctor considers it necessary.
Do not use Timolol maleate (TIMABAK) eye drops solution if the patient is breastfeeding. Timolol may pass into the breast milk.
Ask the doctor for advice before taking any medicine during breastfeeding.
Do not use Timolol maleate (TIMABAK) eye drops solution if the patient is breastfeeding. Timolol may pass into the breast milk.
Ask the doctor for advice before taking any medicine during breastfeeding.
Adverse Reactions
Generalised allergic reactions, hives, localised or generalised skin eruptions, itching, sudden onset & serious allergic reaction; hypoglycaemia; insomnia, depression, nightmares, loss of memory; loss of consciousness, strokes, decreased blood flow to the brain, increase in signs & symptoms of myasthenia gravis, dizziness, unusual sensations & headaches; ocular irritation, inflammation of the eyelid, conjunctival redness, conjunctivitis, inflammation of the cornea, blurred vision & detachment of the sub-retinal layer containing blood vessels following filtration surgery, decreased corneal sensitivity, dry eyes, corneal erosion, upper eyelid sagging, double vision, visual disorders including changes in the refraction index; slow pulse, chest pain, palpitations, oedema, changes in heart rhythm & rate, CHF, heart rhythm disorder, heart attack, heart failure; hypotension, Raynaud's phenomenon, cold hands & feet, claudication; constriction of the pulmonary airways, breathing difficulties, coughing; taste disorders, nausea, indigestion, diarrhoea, dry mouth, abdominal pain, vomiting; hair loss, psoriasis-like outbreaks or worsening of psoriasis, skin eruptions; muscular pain, SLE.
Drug Interactions
If the doctor has prescribed the patient another eye drops solution, the patient must instill this solution 15 minutes before using Timolol maleate (TIMABAK) eye drops solution.
Timolol maleate (TIMABAK) eye drops solution can affect or be affected by other medicines that the patient is using or taking, particularly other eye drops solutions for the treatment of glaucoma.
Tell the doctor of any medicines that the patient is taking or plan to take for hypotension, heart problems or diabetes, quinidine (used to treat heart rhythm disorders and certain types of malaria), or antidepressants such as fluoxetine and paroxetine.
Tell the doctor or pharmacist if the patient is taking or have recently taken another medicine, including a medicine available without a prescription.
Timolol maleate (TIMABAK) eye drops solution can affect or be affected by other medicines that the patient is using or taking, particularly other eye drops solutions for the treatment of glaucoma.
Tell the doctor of any medicines that the patient is taking or plan to take for hypotension, heart problems or diabetes, quinidine (used to treat heart rhythm disorders and certain types of malaria), or antidepressants such as fluoxetine and paroxetine.
Tell the doctor or pharmacist if the patient is taking or have recently taken another medicine, including a medicine available without a prescription.
Storage
Store at a maximum temperature of +25°C.
After first-time opening of the bottle, the eye drops solution can be kept for up to 8 weeks.
Do not use Timolol maleate (TIMABAK) eye drops solution if patient notices visible signs of damage or deterioration.
Medicines should not be disposed of via wastewater or household waste. Ask the pharmacist how to dispose of any unused medicines. Doing this helps to protect the environment.
After first-time opening of the bottle, the eye drops solution can be kept for up to 8 weeks.
Do not use Timolol maleate (TIMABAK) eye drops solution if patient notices visible signs of damage or deterioration.
Medicines should not be disposed of via wastewater or household waste. Ask the pharmacist how to dispose of any unused medicines. Doing this helps to protect the environment.
MedsGo Class
Antiglaucoma Preparations
Features
Brand
Timabak
Full Details
Dosage Strength
5 mg / mL (0.5% w/v)
Drug Ingredients
- Timolol
Drug Packaging
Eye Drops 5ml
Generic Name
Timolol Maleate
Dosage Form
Eye Drops
Registration Number
DR-XY37200
Drug Classification
Prescription Drug (RX)
Product Questions
Questions
